research
∙
11/08/2021
HEROHE Challenge: assessing HER2 status in breast cancer without immunohistochemistry or in situ hybridization
Breast cancer is the most common malignancy in women, being responsible ...
share
research
∙
12/09/2020
Automated Scoring of Nuclear Pleomorphism Spectrum with Pathologist-level Performance in Breast Cancer
Nuclear pleomorphism is the degree of change in nuclear morphology, one ...
research
∙
08/13/2018
